文献速递血栓与止血

活化血小板来源的细胞外囊泡具有富含磷脂的生物分子图谱并增强凝血酶原酶活性

Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity.
PubMed 文献 · J Thromb Haemost · 2024-01-22

本研究采用拉曼镊子微光谱技术对对照与活化血小板的细胞外囊泡(EVs)进行单颗粒或极少量(1-4个)生物分子图谱分析,并系统评估其对凝血系统的影响。活化血小板EVs以蛋白/脂质富集亚群为主(>85%)且富含磷脂,可使凝血酶生成增加52.4%,血浆凝固时间缩短34.6%±10.0%,而对照血小板EVs仅缩短18.6%±13.9%(P=.015),该促凝活性主要由磷脂酰丝氨酸介导。

要点

  • 血小板EVs可分为蛋白富集、蛋白/脂质富集和脂质富集三个亚群。
  • 对照血小板EVs以蛋白富集亚群为主(58.7%±3.5%),活化后以蛋白/脂质富集亚群为主(>85%)。
  • 活化血小板EVs使凝血酶生成增加52.4%,凝血酶原酶复合物活性增加超过6倍。

核心结论

  • 本研究首次报道了血小板活化后血小板EVs具有均一且富含磷脂的生物分子图谱,并伴随磷脂酰丝氨酸依赖性促凝活性增加。
  • 作者认为需进一步研究血小板EVs在静脉血栓栓塞症发病机制中的可能作用。

研究设计与样本

  • 采用拉曼镊子微光谱技术对对照(未刺激)和活化血小板的单个或极少量(1-4个)EVs进行生物分子图谱分析。
  • 系统研究了这些EVs对凝血系统的影响。

主要发现

  • 对照血小板EVs呈现异质性生物分子图谱,蛋白富集亚群为主要亚群(58.7%±3.5%),该亚群可能包含其他细胞外颗粒(包括蛋白聚集体)的少量贡献。
  • 活化血小板EVs更为均一,以蛋白/脂质富集亚群为主(>85%),且富含磷脂。
  • 活化血小板EVs使凝血酶生成增加52.4%,血浆凝固时间缩短34.6%±10.0%,而对照血小板EVs介导的缩短为18.6%±13.9%(P=.015)。
  • 活化血小板EVs使凝血酶原酶复合物(因子Va:FXa:FII)活性增加超过6倍。
  • 增加的促凝活性主要由磷脂酰丝氨酸介导。

局限性

  • 蛋白富集亚群可能包含其他细胞外颗粒(包括蛋白聚集体)的少量贡献。
  • 作者认为需进一步研究血小板EVs在静脉血栓栓塞症发病机制中的可能作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extracellular vesicles (EVs), in particular those derived from activated platelets, are associated with a risk of future venous thromboembolism. OBJECTIVES: To study the biomolecular profile and function characteristics of EVs from control (unstimulated) and activated platelets. METHODS: Biomolecular profiling of single or very few (1-4) platelet-EVs (control/stimulated) was performed by Raman tweezers microspectroscopy. The effects of such EVs on the coagulation system were comprehensively studied. RESULTS: Raman tweezers microspectroscopy of platelet-EVs followed by biomolecular component analysis revealed for the first time 3 subsets of EVs: (i) protein rich, (ii) protein/lipid rich, and (iii) lipid rich. EVs from control platelets presented a heterogeneous biomolecular profile, with protein-rich EVs being the main subset (58.7% ± 3.5%). Notably, the protein-rich subset may contain a minor contribution from other extracellular particles, including protein aggregates. In contrast, EVs from activated platelets were more homogeneous, dominated by the protein/lipid-rich subset (>85%), and enriched in phospholipids. Functionally, EVs from activated platelets increased thrombin generation by 52.4% and shortened plasma coagulation time by 34.6% ± 10.0% compared with 18.6% ± 13.9% mediated by EVs from control platelets (P = .015). The increased procoagulant activity was predominantly mediated by phosphatidylserine. Detailed investigation showed that EVs from activated platelets increased the activity of the prothrombinase complex (factor Va:FXa:FII) by more than 6-fold. CONCLUSION: Our study reports a novel quantitative biomolecular characterization of platelet-EVs possessing a homogenous and phospholipid-enriched profile in response to platelet activation. Such characteristics are accompanied with an increased phosphatidylserine-dependent procoagulant activity. Further investigation of a possible role of platelet-EVs in the pathogenesis of venous thromboembolism is warranted.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Guerreiro EM, Kruglik SG, Swamy S, et al. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity. J Thromb Haemost. 2024. PMID: 38266680. doi:10.1016/j.jtha.2024.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。